BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27158669)

  • 1. Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process.
    Patten PE; Ferrer G; Chen SS; Simone R; Marsilio S; Yan XJ; Gitto Z; Yuan C; Kolitz JE; Barrientos J; Allen SL; Rai KR; MacCarthy T; Chu CC; Chiorazzi N
    JCI Insight; 2016 Apr; 1(4):. PubMed ID: 27158669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
    Fais F; Sellars B; Ghiotto F; Yan XJ; Dono M; Allen SL; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Schuster M; Vinciguerra VP; Rai K; Stevenson FK; Gregersen PK; Ferrarini M; Chiorazzi N
    J Clin Invest; 1996 Oct; 98(7):1659-66. PubMed ID: 8833916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
    Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
    Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
    Ahearne MJ; Willimott S; Piñon L; Kennedy DB; Miall F; Dyer MJ; Wagner SD
    Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice.
    Patten PEM; Ferrer G; Chen SS; Kolitz JE; Rai KR; Allen SL; Barrientos JC; Ioannou N; Ramsay AG; Chiorazzi N
    Front Immunol; 2021; 12():627020. PubMed ID: 33767698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.
    Os A; Bürgler S; Ribes AP; Funderud A; Wang D; Thompson KM; Tjønnfjord GE; Bogen B; Munthe LA
    Cell Rep; 2013 Aug; 4(3):566-77. PubMed ID: 23933259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premalignant cell dynamics in indolent B-cell malignancies.
    Milpied P; Nadel B; Roulland S
    Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
    Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
    Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GALNT11 as a new molecular marker in chronic lymphocytic leukemia.
    Libisch MG; Casás M; Chiribao M; Moreno P; Cayota A; Osinaga E; Oppezzo P; Robello C
    Gene; 2014 Jan; 533(1):270-9. PubMed ID: 24076351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
    Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cells.
    Rodríguez-Caballero A; Henriques A; Criado I; Langerak AW; Matarraz S; López A; Balanzategui A; González M; Nieto WG; Cortesão E; Paiva A; Almeida J; Orfao A
    Br J Haematol; 2015 Jan; 168(2):258-67. PubMed ID: 25252186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations.
    Efremov DG; Ivanovski M; Batista FD; Pozzato G; Burrone OR
    J Clin Invest; 1996 Jul; 98(2):290-8. PubMed ID: 8755637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
    Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
    Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
    Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells.
    Ghamlouch H; Ouled-Haddou H; Guyart A; Regnier A; Trudel S; Claisse JF; Fuentes V; Royer B; Marolleau JP; Gubler B
    Front Immunol; 2014; 5():292. PubMed ID: 24982661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.
    Rigoni M; Riganti C; Vitale C; Griggio V; Campia I; Robino M; Foglietta M; Castella B; Sciancalepore P; Buondonno I; Drandi D; Ladetto M; Boccadoro M; Massaia M; Coscia M
    Oncotarget; 2015 Oct; 6(30):29833-46. PubMed ID: 26284584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression profile associated to apoptosis induced by dexamethasone in CLL cells according to IGHV/ZAP-70 status.
    Baptista MJ; Muntañola A; Calpe E; Abrisqueta P; Salamero O; Fernández E; Codony C; Giné E; Kalko SG; Crespo M; Bosch F
    Clin Cancer Res; 2012 Nov; 18(21):5924-33. PubMed ID: 22966019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
    Stevenson FK; Forconi F; Packham G
    Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.